CAS: 2311-46-8; Isopropyl Hexanoate

相似化合物

142-91-6 110-27-0 112-10-7

上下游产品

CAS号67-63-0 异丙醇 | CAS号142-62-1 正己酸 | CAS号66-25-1 正己醛 | CAS号6378-65-0 己酸己酯 | CAS号111-27-3 正己醇 | CAS号2396-83-0 3-己烯酸乙酯 | CAS号70737-83-6 2-Isopropyloxy-... | CAS号142-61-0 己酰氯 | CAS号2051-49-2 正已酸酐 | CAS号18636-65-2 2-Methyl-3-oxanonane | CAS号66-25-1 正己醛

2-Isopropyloxy-2-N-Pentyl-1,3-Benzoxathiol置于三氟化硼乙醚,Mercury(II) Oxide体系中,用 四氢呋喃,乙醚,水 用作溶剂,化学反应生成己酸异丙酯
参考文献:New Route To Esters From 2-Substituted 1,3-Benzoxathiolium Tetrafluoroborates. An Effective Protection Of Esters Against Nucleophilic Attack
标题:New Route To Esters From 2-Substituted 1,3-Benzoxathiolium Tetrafluoroborates. An Effective Protection Of Esters Against Nucleophilic Attack
摘要:
Doi:10.1055/s-1979-28631

专利信息

专利号:US-9045381-B2
优先权日:2010-10-19
标 题:Ruthenium complexes and their uses in processes for formation and/or hydrogenation of esters, amides and derivatives thereof
发明人：MILSTEIN DAVID; BALARAMAN EKAMBARAM; GUNANATHAN CHIDAMBARAM; GNANAPRAKASAM BOOPATHY; ZHANG JING
权利人:MILSTEIN DAVID; BALARAMAN EKAMBARAM; GUNANATHAN CHIDAMBARAM; GNANAPRAKASAM BOOPATHY; ZHANG JING; YEDA RES & DEV
摘要:The present invention relates to novel Ruthenium catalysts and related borohydride complexes, and the use of such catalysts, inter alia, for (1) hydrogenation of amides (including polyamides) to alcohols and amines; (2) preparing amides from alcohols with amines (including the preparation of polyamides (e.g., polypeptides) by reacting dialcohols and diamines and/or by polymerization of amino alcohols); (3) hydrogenation of esters to alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di-lactones) or polyesters); (4) hydrogenation of organic carbonates (including polycarbonates) to alcohols and hydrogenation of carbamates (including polycarbamates) or urea derivatives to alcohols and amines; (5) dehydrogenative coupling of alcohols to esters; (6) hydrogenation of secondary alcohols to ketones; (7) amidation of esters (i.e., synthesis of amides from esters and amines); (8) acylation of alcohols using esters; (9) coupling of alcohols with water to form carboxylic acids; and (10) dehydrogenation of beta-amino alcohols to form pyrazines. The present invention further relates to the novel uses of certain pyridine Ruthenium catalysts.

专利号:US-5879690-A
优先权日:1995-09-07
标题:Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
发明人：PERRICONE NICHOLAS V
摘要:Compositions for the topical treatment of sagging subcutaneous muscle and overlying cutaneous tissue contain an active ingredient exhibiting or producing catecholamine activity such as catecholamines and/or related compounds in a dermatologically acceptable carrier that contains at least one percutaneous penetration enhancer. Examplary catecholamines include adrenaline, norepinepherine, dopamine and their precursors; catecholamine precursors such as tyrosine and phenylalanine are preferred. Many embodiments, particularly those employing tyrosine and/or phenylalanine as a catecholamine precursor, further contain a neurotransmitter synthesis enhancer such as dimethylaminoethanol, and other co-factors such as vitamin B 6 and pantothenic acid or calcium pantothenate are included in the composition to enhance the action of the active ingredients. Other compounds that scavenge free radicals and antioxidants may also be added.

专利号:CN-113166028-B
优先权日:2018-11-13
标题 :Synthesis of esters using heterogeneous AU/TIO2 catalysts

专利号:US-9650341-B2
优先权日:2010-05-04
标 题 :Process for synthesizing oxidized lactam compounds
发明人：REMENAR JULIUS F; BLUMBERG LAURA COOK; ZEIDAN TAREK A
权利人:ALKERMES PHARMA IRELAND LTD
摘要:The invention provides a method for the synthesis of dehydrogenated lactam drugs of Formula I:

专利号:US-7632519-B2
优先权日:2005-04-25
标 题:TRPV1 agonist compounds, formulations, prodrugs, methods for using the same
发明人：JAMIESON GENE CURTIS; MUHAMMAD NAWEED; BLEY KEITH R
权利人:NEUROGESX INC
摘要:Described here are TRPV1 agonist compounds and their methods of synthesis and use. In addition to specifically identified compounds, capsaicin prodrugs, gemini dimers, and mutual prodrugs are also described. Formulations of the TRPV1 agonist compounds may be in the form of a liquid, tablets, capsules, gel, cream, emulsion, a patch, or the like. Methods for treating medical conditions using the compounds, compositions, or prodrugs described, are also provided.

专利号:CN-103145553-B
优先权日:2013-03-06
标 题:Synthesis and application of 2, 3-alkyl substituted diester succinate